fbpx
11.3 C
London
Tuesday, January 19, 2021

Pharmaceuticals

- Advertisement -

Price Target on Vertex Pharmaceuticals (NASDAQ:VRTX) Dips, Shares Gap Down

NASDAQ:VRTX After SVB Leerink reduced the price target on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) from $283.00 to $267.00, the stocks of the company gapped down before...

Alexion Pharmaceuticals, Inc (NASDAQ: ALXN) Price Target Upgraded To $121.00

Analysts at Morgan Stanley raised the price target of Alexion Pharmaceuticals (NASDAQ: ALXN) to $121.00 on Tuesday. This is up from the earlier $120.00....

Blackstone to acquire Takeda Pharmaceutical’s consumer healthcare unit.

Blackstone to acquire Takeda Pharmaceutical’s consumer healthcare business. Takeda Pharmaceutical values its consumer healthcare unit at £1.75 billion. The deal will result in...

Hikma Pharmaceuticals’ revenue jumps 8% in the fiscal first half.

Hikma Pharmaceuticals' revenue jumps 8% in the fiscal first half. The pharmaceutical firm posts £209.50 million of pre-tax profit in H1. The London-based company upgrades its...
- Advertisement -

Must Read

- Advertisement -